The cosmetics and personal care market is a bright spot for many chemical companies during the recession. Univar Personal, Gelest and Rhodia are among the firms that have indicated continuing demand for cosmetic and personal care products and ingredients. However, customers are switching to more cost-effective brands and products. To continue to attract customers and […]

Early-stage contract research organizations (CROs) could face a tougher time in coming years, according to Jim Miller of PharmSource. After rapid growth in 2007 and early 2008, pharmaceutical outsourcing slowed in late 2008 due to restructuring at large drug companies and efforts to preserve cash by medium- and smaller-size pharmaceutical firms. The number of drug […]

In a paper published this month, the EPA outlined its strategic plans to implement a new approach to chemical toxicity testing. Current approaches rely almost exclusively on animal testing. The new model for toxicity testing and risk assessment is focused on toxicity pathways. Information on the pathways will be combined with distributional data on population […]

According to a report by the US Government Accountability Office (GAO), the three federal agencies charged with detecting seafood fraud—the Department of Homeland Security’s Customs and Border Protection (CBP), the Department of Commerce’s National Marine Fisheries Service (NMFS) and the FDA—are not working together effectively. More than 80% of the five billion pounds of seafood […]

Nearly half of life science companies plan to focus on “breakthrough products and niche markets” in order to mitigate R&D risk, according to a survey by Deloitte Touche Tohmatsu and the Economist Intelligence Unit. The survey is based on responses from 360 life science industry executives from healthcare services (23% of respondents), pharmaceutical R&D (22%), […]

The Information Technology and Innovation Foundation (ITIF) reports that Singapore, Sweden, Luxembourg, Denmark and South Korea are the most competitive and innovative nations out of the 40 nations/regions examined. The study is based on 16 indicators in six categories: human capital, innovation capacity, entrepreneurship, IT infrastructure, economic policy and economic performance. The US ranks sixth, […]

The American Chemistry Council (ACC) has reduced its forecast for US chemical output in 2009. In December 2008, the ACC predicted a 3.1% decline, excluding pharmaceutical chemicals, which has now been revised downward to an 8.7% decrease. Total US chemical production is expected to decline 5.7% in 2009, after falling 3.5% last year. US production […]

The International Service for the Acquisition of Agri-Biotech Applications (ISAAA) reports that the world’s hectarage of biotech crops increased 19.4% to 125 million hectares in 2008. Cropnosis estimates that the market value (based on the sale price of the seed and technology fees) of biotech crops grew 8.7% in 2008 to $7.5 billion to account […]

According to a December 2008 survey by Clinical Laboratory News, the US recession is taking a toll on clinical labs. The e-mailed survey received 254 responses with 63%, 20% and 16% of respondents representing hospital labs, academic medical centers and reference labs, respectively. Thirty-three percent of survey respondents indicated that their labs’ budgets had been […]

Following Pfizer’s plan to acquire Wyeth and Roche’s bid for Genentech, other big pharmaceutical firms may be considering major acquisitions. Sanofi-Aventis is reported to be interested in purchasing Bristol-Myers Squibb (BMS). The companies currently comarket Plavix. However, BMS’s future patent expirations and changes in leadership at Sanofi-Aventis could deter the deal. Merck & Co. has […]